Roche (RHHBY) Release: Health Canada Approves PERJETA, a New First-In-Class Targeted Therapy for the Treatment of HER2-Positive Metastatic Breast Cancer(1)
4/23/2013 10:42:39 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MISSISSAUGA, ON, April 23, 2013 /CNW/ - While awareness and support for breast cancer research is at an all-time high and Canadians "think pink," one-quarter of Canadian women are still not convinced a breast cancer diagnosis may be fatal.2 Yet, breast cancer can be a very aggressive disease and claims the lives of 100 Canadian women every week.3
Help employers find you! Check out all the jobs and post your resume.